Atypical B cells in chronic infectious diseases and systemic autoimmunity: puzzles with many missing pieces. (August 2022)

• Record Type: Journal Article
• Authors: Ambegaonkar, Abhijit A; Holla, Prasida; Dizon, Brian LP; Sohn, Haewon; Pierce, Susan K
• Is Part Of: Current opinion in immunology. Volume 77(2022)
• Publication Date: 2022-08
• Subjects: Immunology -- Periodicals; Allergy -- Periodicals; Immunology -- Abstracts -- Periodicals; Allergy -- Abstracts -- Periodicals; 616.079
• DOI: 10.1016/j.coi.2022.102227
• Languages: English
• ISSNs: 0952-7915

Abstract

Abstract : The world's struggle to contain the SARS-CoV-2 epidemic, primarily through vaccination, has highlighted the importance of better understanding the biology of B cells that participate in defense against infectious diseases, both acute and chronic. Here, we focus on a population of human B cells, termed atypical B cells (ABCs), that comprise a distinct B-cell lineage that differentiates from naive B cells in an interferon-γ-driven process, and are infrequent in healthy individuals but significantly expanded in chronic infectious diseases, including malaria, as well as in systemic autoimmune diseases such as systemic lupus erythematosus (SLE). Recent comparisons of ABCs by single-cell RNAseq provided evidence that ABCs in diverse chronic infectious diseases and in systemic autoimmune diseases are highly related and share common drivers of differentiation and expansion. However, ABCs in different diseases are not identical and also show discrete disease-specific features. Here, we compare and contrast key features of two ABC populations, namely those that are expanded in individuals living in malaria-endemic areas of the world versus those in SLE patients. This comparison is of interest as it appears that unique features of these two diseases result in participation of autoreactive ABCs in parasite-specific responses in malaria but in pathogenic autoimmune responses in SLE. A better understanding of the commonality and differences in the ABC responses in these two diseases may provide critical insights into the development of vaccines that drive pathogen-specific antibody responses and avoid autoimmunity. Highlights: Atypical B cells (ABCs) are expanded in malaria and autoimmune diseases.. ABCs are similar in malaria and SLE but likely play disease-specific roles. They contribute to either protection from malaria or autoimmune disease pathogenesis. In the absence of malaria, ABCs can produce autoantibodies that may lead to autoimmune disease.